Skip to content
Disclosery

Chicago Capital Management, LLC

Follow

13F filer, CIK 1580162, CHICAGO, IL

Chicago Capital Management, LLC reported $112,300,553 across 27 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-07-22. Its ten largest share positions make up 65.67% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001062993-26-003767

Period
2026-06-30
Reported value
$112M
Holdings
27
Top 10 weight
65.67%
New
14
Sold out
16

Largest buys vs the previous quarter

SecurityShares changeApprox. value
NUVLnew+115,500$11.1M
APGEnew+97,100$9.81M
TMHCnew+133,000$7.17M
CPRXnew+122,650$2.93M
ALOTnew+131,100$2.85M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
JHGexited-213,000-$8.22M
ACLXexited-92,951-$8.04M
FOLDexited-666,000-$7.23M
APLSexited-190,000-$5.76M
TERNexited-129,225-$5.14M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0001062993-26-003767, largest first. % of portfolio is the value over $112,300,553, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NUVLNUVALENT INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 115,500 shares 115,500$11.1M9.84%newTimeline
APGEAPOGEE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 97,100 shares 97,100$9.81M8.73%newTimeline
GTLSCHART INDS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 53,000 shares; 2026Q2: 53,000 shares 53,000$8.36M7.44%0Timeline
TMHCTAYLOR MORRISON HOME CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 133,000 shares 133,000$7.17M6.39%newTimeline
HEWLETT PACKARD ENTERPRISE CHEWLETT PACKARD ENTERPRISE CQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 32,900 shares; 2025Q2: 32,900 shares; 2025Q3: 32,900 shares; 2025Q4: 32,900 shares; 2026Q1: 32,900 shares; 2026Q2: 32,900 shares 32,900$3.81M3.39%0
CPRXCATALYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 122,650 shares 122,650$2.93M2.61%newTimeline
ALOTASTRONOVA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 131,100 shares 131,100$2.85M2.54%newTimeline
ESPRESPERION THERAPEUTICS INC NEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 830,935 shares 830,935$2.61M2.32%newTimeline
TECHBIO-TECHNE CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 37,509 shares 37,509$2.02M1.8%newTimeline
TBRGTRUBRIDGE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 34,663 shares 34,663$686K0.61%newTimeline
STELSTELLAR BANCORP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 11,559 shares 11,559$342K0.3%newTimeline
EAELECTRONIC ARTS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,000 shares; 2026Q1: 2,000 shares; 2026Q2: 2,000 shares 2,000$309K0.28%0Timeline
NSTSNSTS BANCORP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 29,020 shares 29,020$304K0.27%newTimeline
XRXDWXEROX HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 95,980 shares 95,980$26.4K0.02%newTimeline

Principal amounts

Notes and convertibles filed as a face amount (PRN). A face amount is never added to a share count (H6).

SecurityTypeAmountValueChange
BANDWIDTH INCBANDWIDTH INC NOTE 0.500% 4/0principal8,153$7.62M+13
SABRE GLBL INCSABRE GLBL INC NOTE 7.320% 8/0principal6,904$7.12M+946
RAPID7 INCRAPID7 INC NOTE 0.250% 3/1principal6,520$6.31M+2,002
MGP INGREDIENTS INC NEWMGP INGREDIENTS INC NEW NOTE 1.875%11/1principal6,068$5.93M+50
VERITONE INCVERITONE INC NOTE 1.750%11/1principal5,500$5.39M+3,000
AMPHASTAR PHARMACEUTICALS INAMPHASTAR PHARMACEUTICALS IN NOTE 2.000% 3/1principal5,440$4.98Mnew
THE REALREAL INCTHE REALREAL INC CNVprincipal5,307$4.78M0
FIVE9 INCFIVE9 INC CNVprincipal5,000$4.48Mnew
SHAKE SHACK INCSHAKE SHACK INC NOTE 3/0principal4,189$3.97M0
ETSY INCETSY INC NOTE 0.250% 6/1principal4,292$3.93M0
SAREPTA THERAPEUTICS INCSAREPTA THERAPEUTICS INC NOTE 1.250% 9/1principal3,170$3Mnew
XEROX HOLDINGS CORPXEROX HOLDINGS CORP NOTE 3.750% 3/1principal4,000$1.44M0
PAR TECHNOLOGY CORPPAR TECHNOLOGY CORP NOTE 1.500%10/1principal1,127$1.07M0

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
JHGJANUS HENDERSON GROUP PLC213,000$8.22Mshares
ACLXARCELLX INC92,951$8.04Mshares
FOLDAMICUS THERAPEUTIC666,000$7.23Mshares
IRONWOOD PHARMACEUTICALS INCIRONWOOD PHARMACEUTICALS INC7,000$6.91Mprincipal
CRACKER BARREL OLD CTRY STORCRACKER BARREL OLD CTRY STOR6,883$6.81Mprincipal
ACCURAY INC DELACCURAY INC DEL6,500$6.28Mprincipal
APLSAPELLIS PHARMACEUTICALS INC190,000$5.76Mshares
TERNTERNS PHARMACEUTICALS INC129,225$5.14Mshares
NABORS INDS INCNABORS INDS INC4,550$4.16Mprincipal
LITHIUM ARGENTINA AGLITHIUM ARGENTINA AG3,820$3.7Mprincipal
ASSERTIO HOLDINGS INCASSERTIO HOLDINGS INC2,750$2.64Mprincipal
DHILDIAMOND HILL INVT GROUP INC11,300$1.46Mshares
BLFYBLUE FOUNDRY BANCORP146,012$1.45Mshares
THRTHERMON GROUP HLDGS INC30,069$1.14Mshares
DAWNDAY ONE BIOPHARMACEUTICALS I10,000$162Kshares
HTBKHERITAGE COMM CORP14,014$132Kshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001062993-26-003767 base2026-07-22acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0001062993-26-003767 Quarter ended 2026-06-302026-07-22acceptance time not in the bulk data set
13F-HR 0001062993-26-002171 Quarter ended 2026-03-312026-04-27acceptance time not in the bulk data set
13F-HR 0001062993-26-000528 Quarter ended 2025-12-312026-02-02acceptance time not in the bulk data set
13F-HR 0001062993-25-016555 Quarter ended 2025-09-302025-11-07acceptance time not in the bulk data set
13F-HR 0001062993-25-013796 Quarter ended 2025-06-302025-08-07acceptance time not in the bulk data set
13F-HR 0001062993-25-009036 Quarter ended 2025-03-312025-05-09acceptance time not in the bulk data set
13F-HR 0001062993-25-002121 Quarter ended 2024-12-312025-02-12acceptance time not in the bulk data set
13F-HR 0001062993-24-018687 Quarter ended 2024-09-302024-11-08acceptance time not in the bulk data set
13F-HR 0001062993-24-014998 Quarter ended 2024-06-302024-08-14acceptance time not in the bulk data set
13F-HR 0001062993-24-009808 Quarter ended 2024-03-312024-05-09acceptance time not in the bulk data set
13F-HR 0001062993-24-002912 Quarter ended 2023-12-312024-02-13acceptance time not in the bulk data set
13F-HR 0001062993-23-020719 Quarter ended 2023-09-302023-11-14acceptance time not in the bulk data set
13F-HR 0001062993-23-016313 Quarter ended 2023-06-302023-08-14acceptance time not in the bulk data set
13F-HR 0001062993-23-010832 Quarter ended 2023-03-312023-05-11acceptance time not in the bulk data set
13F-HR 0001062993-23-002950 Quarter ended 2022-12-312023-02-14acceptance time not in the bulk data set
13F-HR 0001062993-22-021757 Quarter ended 2022-09-302022-11-09acceptance time not in the bulk data set
13F-HR 0001062993-22-016764 Quarter ended 2022-06-302022-07-27acceptance time not in the bulk data set
13F-HR 0001062993-22-012019 Quarter ended 2022-03-312022-05-11acceptance time not in the bulk data set
13F-HR 0001062993-22-001753 Quarter ended 2021-12-312022-01-28acceptance time not in the bulk data set
13F-HR 0001062993-21-010603 Quarter ended 2021-09-302021-11-12acceptance time not in the bulk data set
13F-HR 0001062993-21-007319 Quarter ended 2021-06-302021-08-11acceptance time not in the bulk data set
13F-HR 0001062993-21-004072 Quarter ended 2021-03-312021-05-04acceptance time not in the bulk data set
13F-HR 0001062993-21-001176 Quarter ended 2020-12-312021-02-10acceptance time not in the bulk data set
13F-HR 0001062993-20-005421 Quarter ended 2020-09-302020-11-06acceptance time not in the bulk data set
13F-HR 0001062993-20-003885 Quarter ended 2020-06-302020-08-13acceptance time not in the bulk data set
13F-HR 0001062993-20-002360 Quarter ended 2020-03-312020-05-14acceptance time not in the bulk data set
13F-HR 0001062993-20-000688 Quarter ended 2019-12-312020-02-12acceptance time not in the bulk data set
13F-HR 0001062993-19-004452 Quarter ended 2019-09-302019-11-14acceptance time not in the bulk data set
13F-HR 0001062993-19-003314 Quarter ended 2019-06-302019-08-12acceptance time not in the bulk data set
13F-HR 0001062993-19-002157 Quarter ended 2019-03-312019-05-13acceptance time not in the bulk data set
13F-HR 0001062993-19-000667 Quarter ended 2018-12-312019-02-12acceptance time not in the bulk data set
13F-HR 0001062993-18-004483 Quarter ended 2018-09-302018-11-09acceptance time not in the bulk data set
13F-HR 0001062993-18-003264 Quarter ended 2018-06-302018-08-10acceptance time not in the bulk data set
13F-HR 0001062993-18-002007 Quarter ended 2018-03-312018-05-09acceptance time not in the bulk data set
13F-HR 0001062993-18-000369 Quarter ended 2017-12-312018-01-31acceptance time not in the bulk data set
13F-HR 0001062993-17-004395 Quarter ended 2017-09-302017-10-11acceptance time not in the bulk data set
13F-HR 0001062993-17-003245 Quarter ended 2017-06-302017-07-17acceptance time not in the bulk data set
13F-HR 0001062993-17-001789 Quarter ended 2017-03-312017-04-10acceptance time not in the bulk data set
13F-HR 0001062993-17-000205 Quarter ended 2016-12-312017-01-13acceptance time not in the bulk data set
13F-HR 0001062993-16-011825 Quarter ended 2016-09-302016-10-21acceptance time not in the bulk data set
13F-HR 0001062993-16-010582 Quarter ended 2016-06-302016-07-15acceptance time not in the bulk data set
13F-HR 0001062993-16-009260 Quarter ended 2016-03-312016-04-28acceptance time not in the bulk data set
13F-HR 0001062993-16-007183 Quarter ended 2015-12-312016-01-21acceptance time not in the bulk data set
13F-HR 0001062993-15-005612 Quarter ended 2015-09-302015-10-27acceptance time not in the bulk data set
13F-HR 0001062993-15-004272 Quarter ended 2015-06-302015-08-10acceptance time not in the bulk data set
13F-HR 0000950123-15-005897 Quarter ended 2015-03-312015-05-14acceptance time not in the bulk data set